Ubrelvy 100 MG tablet UD 16S
Ended Awarded
- Contract number
- SPE2DB25FRK25
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,695
Award facts
- Contract value 100% obligated
- $12,694.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packaging (16 count). The contract, valued at $12,694.80, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award authority. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and extending through December 2026. This parent contract enables AmerisourceBergen to supply comprehensive pharmaceutical products and medical commodities globally to support military healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare operations. The company maintains an extensive portfolio of federal contracts covering a broad range of medications and medical supplies across multiple therapeutic areas. As a child delivery order under the DLA's pharmaceutical prime vendor program, this UBRELVY order fulfills routine medical supply needs within AmerisourceBergen's existing framework to support active military and veteran healthcare operations. The contract is scheduled for ultimate completion by July 11, 2025, reflecting the expedited delivery timeline typical of pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FRK25?
SPE2DB25FRK25 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 10, 2025.
How much is contract SPE2DB25FRK25 worth?
The government has obligated $12,695 on SPE2DB25FRK25.
Is contract SPE2DB25FRK25 an order under another contract?
Yes. SPE2DB25FRK25 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRK25 competed?
The extent of competition for SPE2DB25FRK25 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award